Use of the NMDA antagonist magnesium sulfate during monitored anesthesia care for shockwave lithotripsy

Journal of Endourology

Volumn 21, Issue 2, 2007, Pages 145-150

  Kaymak, Cetin ^a   Yilmaz, Erdal ^a,b   Basar, Hulya ^a   Ozcakir, Sibel ^a   Apan, Alpaslan ^a   Batislam, Ertan ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MAGNESIUM SULFATE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ANESTHESIA INDUCTION; ARTERIAL OXYGEN TENSION; ARTICLE; BISPECTRAL INDEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG USE; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FLUSHING; HEMODYNAMICS; HUMAN; INFUSION RATE; MALE; MONITORED ANESTHESIA CARE; OBSERVER ASSESSMENT SEDATION SCORE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SIDE EFFECT; UROLITHIASIS; VISUAL ANALOG SCALE;

ADULT; ANALGESICS; ANESTHESIA; BLOOD PRESSURE; CONSCIOUS SEDATION; DEMOGRAPHY; FEMALE; FENTANYL; HEART RATE; HUMANS; LITHOTRIPSY; MAGNESIUM SULFATE; MALE; MIDAZOLAM; OXYGEN; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 33947406415     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.0195     Document Type: Article

References (24)

1. Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet 1980;2:1265.
2. Ghisi D, Fanelli A, Tosi M, et al. Monitored anesthesia care. Minerva Anestesiol 2005;71:533.
3. Liu J, Singh H, White PF: Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology 1996;84:64.
4. Rao MP, Kumar S, Dutta B, et al. Safety and efficacy of ureteroscopic lithotripsy for urethral calculi under sedoanalgesia: A prospective study. Int Urol Nephrol 2005;37:219.
5. Cortinez LI, Munoz HR, Fuente R de la, et al. Target-controlled infusion of remifentanil or fentanyl during extracorporeal shockwave lithotripsy. Eur J Anaesthesiol 2005;22:56.
6. Monk TG, Boure B, White PF, et al. Comparison of intravenous sedative-analgesic techniques for outpatient immersion lithotripsy. Anesth Analg 1991;72:616.
7. Gesztesi Z, Rego MM, White PF. The comparative effectiveness of fentanyl and its newer analog during extracorporeal shock wave lithotripsy under monitored anesthesia care. Anesth Analg 2000;90: 567.
8. Monk TG, Rater JM, White PF. Comparison of alfentanil and ketamine infusions in combination with midazolam for outpatient lithotripsy. Anesthesiology 1991;74:1023.
9. Basar H, Yilmaz E, Ozcan S, et al. Four analgesic techniques for shockwave lithotripsy: Eutectic mixture local anesthetic is a good alternative. J Endourol 2003;17:3.
10. Richardson MG, Dooley JW. The effects of general versus epidural anesthesia for outpatient extracorporeal shock wave lithotripsy. Anesth Analg 1998;86:1214.
11. Fawcett WJ, Haxby EJ, Male DA. Magnesium: Physiology and pharmacology. Br J Anaesth 1999;83:302.
12. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: Implications for the treatment of post injury pain and hypersensitivity states. Pain 1991;44:293.
13. Dickenson AH. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990;11:307.
14. Tramer MR, Schneider J, Marti RA, et al. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996;84:340.
15. Koinig H, Wallner T, Marhofer P, et al. Magnesium sulfate reduces intra- and postoperative analgesic requirements. Anesth Analg 1998;87:206.
16. Wilder-Smith OHG, Arendt-Nielsen L, Gaumann D, et al. Sensory changes and pain after abdominal hysterectomy: A comparison of anesthetic supplementation with fentanyl versus magnesium or ketamine. Anesth Analg 1998;86:95.
17. Telci L, Esen F, Akcora D, et al. Evaluation of effects of magnesium sulphate in reducing intraoperative anaesthetic requirements. Br J Anaesth 2002;89:594.
18. Apan A, Buyukkocak U, Ozcan S, et al. Postoperative magnesium infusion reduces analgesic requirements in spinal anaesthesia. Eur J Anaesthesiol 2004;21:766.
19. Memiş, D, Turan A, Karamanlioǧlu B, et al. Comparison of sufentanil with sufentanil plus magnesium sulphate for sedation in the intensive care unit using bispectral index. Crit Care 2003;7:123.
20. Salinas AS, Lorenzo-Romero J, Segura M, et al. Factors determining analgesic and sedative drug requirements during extracorporeal shock wave lithotripsy. Urol Int 1999;63:92.
21. Dundee JW, Halliday NJ, Harper KW, et al. Midazolam: A review of its pharmacological properties and therapeutic use. Drugs 1984;28:519.
22. Marrannes R, Willems R, De Prins E, et al. Evidence for a role of N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res 1988;457:226.
23. Mason BA, Standley CA, Irtnkauf SM, et al. Magnesium is more efficacious than phenytoin in reducing N-methyl-D-aspartate seizures in rats. Am J Obstet Gynecol 1994;171:999.
24. Begum R, Begum A, Bullough CH, et al. Reducing maternal from eclampsia, using magnesium sulphate. Eur J Obstet Gynecol Reprod Biol 2000;92:223.